Veracyte, Inc.VCYTNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, slight contraction.
Left:
||||
Year-over-year research & development expense growth
Latest
20.92%
↓ 11% below average
Average (9y)
23.53%
Historical baseline
Range
High:73.47%
Low:-9.42%
CAGR
-4.1%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 20.92% |
| 2023 | 41.13% |
| 2022 | 36.06% |
| 2021 | 73.47% |
| 2020 | 15.84% |
| 2019 | 0.21% |
| 2018 | 6.76% |
| 2017 | -9.42% |
| 2016 | 19.76% |
| 2015 | 30.52% |